Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.

Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.

Item
http://www.wikidata.org/entity/Q34763661
Pharmacodynamic modelling of biomarker data in oncology.The interconnectedness of cancer cell signaling.A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancerMulti-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer.Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cellsResistance to BH3 mimetic S1 in SCLC cells that up-regulate and phosphorylate Bcl-2 through ERK1/2.Cancer subclonal genetic architecture as a key to personalized medicine.Emerging drugs for small cell lung cancer--an update.Small molecules as pro-apoptotic anticancer agents.Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration
P2860

Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.

Item
http://www.wikidata.org/entity/Q34763661
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Optimization of circulating bi ...... s with small cell lung cancer.
@ast
Optimization of circulating bi ...... s with small cell lung cancer.
@en
Optimization of circulating bi ...... s with small cell lung cancer.
@nl
type
label
Optimization of circulating bi ...... s with small cell lung cancer.
@ast
Optimization of circulating bi ...... s with small cell lung cancer.
@en
Optimization of circulating bi ...... s with small cell lung cancer.
@nl
prefLabel
Optimization of circulating bi ...... s with small cell lung cancer.
@ast
Optimization of circulating bi ...... s with small cell lung cancer.
@en
Optimization of circulating bi ...... s with small cell lung cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Optimization of circulating bi ...... s with small cell lung cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932